Dr. James Lilly, MD

NPI: 1356327423
Total Payments
$15,188
2024 Payments
$12,067
Companies
7
Transactions
45

Payment Breakdown by Category

Research$8,430 (55.5%)
Travel$4,987 (32.8%)
Food & Beverage$1,772 (11.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $8,430 3 55.5%
Travel and Lodging $4,987 19 32.8%
Food and Beverage $1,772 23 11.7%

Payments by Type

Research
$8,430
3 transactions
General
$6,759
42 transactions

Top Paying Companies

Company Total Records Latest Year
Eli Lilly and Company $9,997 18 $0 (2024)
Merck Sharp & Dohme LLC $2,069 11 $0 (2024)
ModernaTX, Inc. $1,461 4 $0 (2023)
GlaxoSmithKline, LLC. $771.95 2 $0 (2023)
Janssen Research & Development, LLC $620.00 8 $0 (2022)
Echosens North America, Inc. $257.23 1 $0 (2022)
Allergan Inc. $12.07 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,067 29 Eli Lilly and Company ($9,997)
2023 $2,233 6 ModernaTX, Inc. ($1,461)
2022 $877.23 9 Janssen Research & Development, LLC ($620.00)
2017 $12.07 1 Allergan Inc. ($12.07)

All Payment Transactions

45 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/17/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $339.00 General
06/17/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $339.00 General
06/17/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $320.00 General
06/17/2024 Eli Lilly and Company Food and Beverage In-kind items and services $118.73 General
06/17/2024 Eli Lilly and Company Food and Beverage In-kind items and services $51.79 General
06/17/2024 Eli Lilly and Company Food and Beverage In-kind items and services $51.01 General
06/17/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $42.98 General
06/17/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $42.98 General
06/17/2024 Eli Lilly and Company Food and Beverage In-kind items and services $32.96 General
06/17/2024 Eli Lilly and Company Food and Beverage In-kind items and services $32.96 General
06/17/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $32.00 General
06/17/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $15.00 General
06/17/2024 Eli Lilly and Company Food and Beverage In-kind items and services $14.12 General
06/17/2024 Eli Lilly and Company Food and Beverage In-kind items and services $14.12 General
06/16/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $573.09 General
06/16/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $162.46 General
06/16/2024 Eli Lilly and Company Travel and Lodging In-kind items and services $157.63 General
05/21/2024 Merck Sharp & Dohme LLC Travel and Lodging In-kind items and services $280.62 General
Category: ENDOCRINOLOGY
05/21/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $64.99 General
Category: ENDOCRINOLOGY
05/21/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $39.98 General
Category: ENDOCRINOLOGY
05/21/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $27.74 General
Category: ENDOCRINOLOGY
05/20/2024 Merck Sharp & Dohme LLC Travel and Lodging In-kind items and services $280.62 General
Category: ENDOCRINOLOGY
05/20/2024 Merck Sharp & Dohme LLC Travel and Lodging In-kind items and services $180.93 General
Category: ENDOCRINOLOGY
05/20/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $115.68 General
Category: ENDOCRINOLOGY
05/20/2024 Merck Sharp & Dohme LLC Travel and Lodging In-kind items and services $98.73 General
Category: ENDOCRINOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) Eli Lilly and Company $7,658 1
A DOUBLE-BLIND, DOUBLE DUMMY, RANDOMIZED, PHASE 1B, NITROFURANTOIN CON GlaxoSmithKline, LLC. $771.95 2

About Dr. James Lilly, MD

Dr. James Lilly, MD is a Emergency Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356327423.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Lilly, MD has received a total of $15,188 in payments from pharmaceutical and medical device companies, with $12,067 received in 2024. These payments were reported across 45 transactions from 7 companies. The most common payment nature is "" ($8,430).

Practice Information

  • Specialty Emergency Medicine
  • Location Dallas, TX
  • Active Since 12/20/2005
  • Last Updated 09/22/2011
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1356327423

Products in Payments

  • FibroScan (Device) $257.23
  • TEFLARO (Drug) $12.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Dallas